Amedisys Analysis
| AMEDDelisted Stock | USD 100.99 0.03 0.03% |
Amedisys is overvalued with Real Value of 84.21 and Hype Value of 100.85. The main objective of Amedisys delisted stock analysis is to determine its intrinsic value, which is an estimate of what Amedisys is worth, separate from its market price. There are two main types of Amedisys' stock analysis: fundamental analysis and technical analysis.
The Amedisys stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Amedisys' ongoing operational relationships across important fundamental and technical indicators.
Amedisys |
Amedisys Stock Analysis Notes
About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Amedisys was presently reported as 37.48. The company has Price/Earnings To Growth (PEG) ratio of 1.47. Amedisys had not issued any dividends in recent years. The entity had 4:3 split on the 5th of December 2006. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 21000 people. For more info on Amedisys please contact Richard Ashworth at 225 292 2031 or go to https://www.amedisys.com.Amedisys Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amedisys' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amedisys or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Amedisys is not yet fully synchronised with the market data | |
| Amedisys has a very high chance of going through financial distress in the upcoming years | |
| Over 96.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: 2,309 Shares in The Ensign Group, Inc. ENSG Bought by Voleon Capital Management LP |
Amedisys Upcoming and Recent Events
| 21st of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Amedisys Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.32 B.Amedisys Profitablity
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.Amedisys Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amedisys insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amedisys' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amedisys insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amedisys Outstanding Bonds
Amedisys issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amedisys uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amedisys bonds can be classified according to their maturity, which is the date when Amedisys has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AMCR 3625 28 APR 26 Corp BondUS02343UAG04 | View | |
| AMCR 45 15 MAY 28 Corp BondUS02343UAH86 | View | |
| AMCR 269 25 MAY 31 Corp BondUS02344AAA60 | View | |
| DOX 2538 15 JUN 30 Corp BondUS02342TAE91 | View |
Amedisys Predictive Daily Indicators
Amedisys intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Amedisys stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Amedisys Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Amedisys prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amedisys shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Amedisys. By using and applying Amedisys Stock analysis, traders can create a robust methodology for identifying Amedisys entry and exit points for their positions.
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 21000 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Amedisys to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in commodities. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Amedisys Stock
If you are still planning to invest in Amedisys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedisys' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |